The results showed that the expression of CXCL9 in tumour tissues of the NE + anti-PD-1 mAb + Vehicle group was significantly lower than that in the CTRL + Vehicle and anti-PD-1 mAb + Vehicle groups (Fig. 2b). Here, CXCL9 is linked to neoplasm.